Suppr超能文献

增加适当的BRCA1/2基因检测:家族史记录和遗传咨询在多学科诊所中的作用

Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.

作者信息

Kishan Amar U, Gomez Caitlin L, Dawson Nicole A, Dvorak Robyn, Foster Nova M, Hoyt Anne, Hurvitz Sara A, Kusske Amy, Silver Erica L, Tseng Charles, McCloskey Susan A

机构信息

Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA, USA.

出版信息

Ann Surg Oncol. 2016 Dec;23(Suppl 5):634-641. doi: 10.1245/s10434-016-5545-0. Epub 2016 Sep 12.

Abstract

BACKGROUND

Findings show that 5-10 % of women with a diagnosis of breast cancer (BCa) have actionable genetic mutations. The National Comprehensive Cancer Network guidelines for testing to detect BRCA1/2 mutations include personal history (PH) variables such as age of 45 years or younger and a family history (FH) variables. Rates of FH documentation and overall rates of appropriate referral for genetic testing are low, ranging from about 30 to 60 %. The authors hypothesized that an upfront FH documentation and inclusion of a genetics counselor in a multidisciplinary clinic (MDC) setting would increase rates of appropriate referral for genetic testing.

METHODS

The study enrolled 609 consecutive women with non-metastatic BCa seen in consultation between June 2012 and December 2015 at a multidisciplinary clinic. Rates of FH documentation and referral for genetic testing to detect BRCA1/2 mutations were assessed before and after inclusion of a genetic counselor in the MDC.

RESULTS

The rates of FH documentation and appropriate referral were 100 and 89 %, respectively. Half (50 %) of the patients had only FH-based indications for testing. All the patients with PH-based indications were referred. The inclusion of a genetic counselor significantly increased appropriate referral rates among those with only FH-based indications (62 vs. 92 %) and overall (80 vs. 96 %) (p < 0.0001 for both). Among the 12 % of the patients with actionable mutations, 60 % were 45 years of age or younger, whereas 30 % had only FH-based testing indications.

CONCLUSIONS

This report shows substantially higher FH documentation and appropriate genetic testing rates than prior reports. Many patients with indications for genetic testing may have only FH-based indications for testing, and this subset may account for the sizable proportion of patients with newly diagnosed BCa who have actionable mutations.

摘要

背景

研究结果显示,5%至10%被诊断患有乳腺癌(BCa)的女性存在可采取行动的基因突变。美国国立综合癌症网络关于检测BRCA1/2突变的指南包括个人史(PH)变量,如45岁及以下年龄,以及家族史(FH)变量。FH记录率和基因检测的适当转诊总率较低,约为30%至60%。作者推测,在多学科诊所(MDC)环境中预先进行FH记录并纳入遗传咨询师将提高基因检测的适当转诊率。

方法

该研究纳入了2012年6月至2015年12月期间在一家多学科诊所会诊的609例连续的非转移性BCa女性患者。在MDC中纳入遗传咨询师之前和之后,评估了FH记录率和检测BRCA1/2突变的基因检测转诊率。

结果

FH记录率和适当转诊率分别为100%和89%。一半(50%)的患者仅有基于FH的检测指征。所有有基于PH指征的患者均被转诊。纳入遗传咨询师显著提高了仅有基于FH指征患者(62%对92%)以及总体患者(80%对96%)的适当转诊率(两者p均<0.0001)。在12%存在可采取行动突变的患者中,60%年龄在45岁及以下,而30%仅有基于FH的检测指征。

结论

本报告显示FH记录率和适当基因检测率比之前的报告高得多。许多有基因检测指征的患者可能仅有基于FH的检测指征,并且这一亚组可能占新诊断BCa且存在可采取行动突变患者的相当大比例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验